EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 170 filers reported holding EXELIXIS INC in Q2 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $557,000 | -75.2% | 31,512 | -70.0% | 0.05% | -50.0% |
| Q2 2019 | $2,246,000 | -8.6% | 105,097 | +1.9% | 0.10% | -4.8% |
| Q1 2019 | $2,456,000 | +15.6% | 103,177 | -14.0% | 0.10% | +34.6% |
| Q3 2018 | $2,125,000 | +31.9% | 119,945 | +60.3% | 0.08% | +34.5% |
| Q2 2018 | $1,611,000 | +531.8% | 74,843 | +550.4% | 0.06% | +480.0% |
| Q1 2018 | $255,000 | -91.7% | 11,508 | -90.9% | 0.01% | -91.3% |
| Q3 2017 | $3,078,000 | +52.9% | 127,049 | +55.5% | 0.12% | +51.3% |
| Q2 2017 | $2,013,000 | -51.2% | 81,713 | -57.1% | 0.08% | -51.6% |
| Q1 2017 | $4,127,000 | +102.1% | 190,454 | +39.0% | 0.16% | +89.2% |
| Q4 2016 | $2,042,000 | +2095.7% | 136,975 | +487.2% | 0.08% | +1975.0% |
| Q1 2016 | $93,000 | +66.1% | 23,325 | +132.9% | 0.00% | +100.0% |
| Q4 2015 | $56,000 | – | 10,017 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |